Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018 (2018), Article ID 8296451, 10 pages
https://doi.org/10.1155/2018/8296451
Research Article

Protective Effect of Boswellic Acids against Doxorubicin-Induced Hepatotoxicity: Impact on Nrf2/HO-1 Defense Pathway

1Department of Pharmacology and Toxicology, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt
2Department of Biochemistry, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt
3Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt

Correspondence should be addressed to Bassant M. Barakat; moc.oohay@takarab.tnassab

Received 8 October 2017; Accepted 19 December 2017; Published 6 February 2018

Academic Editor: Simona G. Bungău

Copyright © 2018 Bassant M. Barakat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Superfin, A. A. Iannucci, and A. M. Davies, “Commentary: oncologic drugs in patients with organ dysfunction: a summary,” The Oncologist, vol. 12, no. 9, pp. 1070–1083, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. H. Thippeswamy, A. Shirodkar, B. C. Koti et al., “Protective role of Phyllantus niruri extract in doxorubicin-induced myocardial toxicity in rats,” Indian Journal of Pharmacology, vol. 43, no. 1, pp. 31–35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Craig Henderson and E. Frei 3rd, “Adriamycin cardiotoxicity,” American Heart Journal, vol. 99, no. 5, pp. 671–674, 1980. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Injac, M. Perse, M. Cerne et al., “Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer,” Biomaterials, vol. 30, no. 6, pp. 1184–1196, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Kolarovic, M. Popovic, J. Zlinská, S. Trivic, and M. Vojnovic, “Antioxidant activities of celery and parsley juices in rats treated with doxorubicin,” Molecules, vol. 15, no. 9, pp. 6193–6204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. L. O. Somova, A. Nadar, P. Rammanan, and F. O. Shode, “Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension,” Phytomedicine, vol. 10, no. 2-3, pp. 115–121, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Liu, “Pharmacology of oleanolic acid and ursolic acid,” Journal of Ethnopharmacology, vol. 49, no. 2, pp. 57–68, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Li, X. Zhang, L. Cui et al., “Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice,” Brain Research, vol. 1497, pp. 32–39, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. R. Hartmann, M. I. Morgan Martins, J. Tieppo, H. S. Fillmann, and N. P. Marroni, “Effect of Boswellia serrata on antioxidant status in an experimental model of colitis rats induced by acetic acid,” Digestive Diseases and Sciences, vol. 57, no. 8, pp. 2038–2044, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. S. M. Elshazly, D. M. Abd El Motteleb, and N. N. Nassar, “The selective 5-LOX inhibitor 11-keto-β-boswellic acid protects against myocardial ischemia reperfusion injury in rats: involvement of redox and inflammatory cascades,” Naunyn-Schmiedeberg’s Archives of Pharmacology, vol. 386, no. 9, pp. 823–833, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Ali and S. Mansour, “Boswellic acids extract attenuates pulmonary fibrosis induced by bleomycin and oxidative stress from gamma irradiation in rats,” Chinese Medicine, vol. 6, no. 1, p. 36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Safayhi, T. Mack, J. Sabieraj, M. I. Anazodo, L. R. Subramanian, and H. P. Ammon, “Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase,” The Journal of Pharmacology and Experimental Therapeutics, vol. 261, no. 3, pp. 1143–1146, 1992. View at Google Scholar
  13. M. C. Yin, M. C. Lin, M. C. Mong, and C. Y. Lin, “Bioavailability, distribution, and antioxidative effects of selected triterpenes in mice,” Journal of Agricultural and Food Chemistry, vol. 60, no. 31, pp. 7697–7701, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Zhang, J. Jia, Y. Ding et al., “Alpha-boswellic acid protects against ethanol-induced gastric injury in rats: involvement of nuclear factor erythroid-2-related factor 2/heme oxygenase-1 pathway,” The Journal of Pharmacy and Pharmacology, vol. 68, no. 4, pp. 514–522, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Chan and Y. W. Kan, “Nrf2 is essential for protection against acute pulmonary injury in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 22, pp. 12731–12736, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Enomoto, K. Itoh, E. Nagayoshi et al., “High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes,” Toxicological Sciences, vol. 59, no. 1, pp. 169–177, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. J. W. Fahey, X. Haristoy, P. M. Dolan et al., “Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 11, pp. 7610–7615, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. L. E. Otterbein, M. P. Soares, K. Yamashita, and F. H. Bach, “Heme oxygenase-1: unleashing the protective properties of heme,” Trends in Immunology, vol. 24, no. 8, pp. 449–455, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. Q. Lin, S. Weis, G. Yang et al., “Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress,” The Journal of Biological Chemistry, vol. 282, no. 28, pp. 20621–20633, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. S. A. Ali, S. A. Zaitone, and Y. M. Moustafa, “Boswellic acids synergize antitumor activity and protect against the cardiotoxicity of doxorubicin in mice bearing Ehrlich’s carcinoma,” Canadian Journal of Physiology and Pharmacology, vol. 93, no. 8, pp. 695–708, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Satoh, “Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method,” Clinica Chimica Acta, vol. 90, no. 1, pp. 37–43, 1978. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Publisher · View at Google Scholar · View at Scopus
  23. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Publisher · View at Google Scholar · View at Scopus
  24. R. G. Knodell, K. G. Ishak, W. C. Black et al., “Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis,” Hepatology, vol. 1, no. 5, pp. 431–435, 1981. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Krishnaiah, R. Sarbatly, and R. Nithyanandam, “A review of the antioxidant potential of medicinal plant species,” Food and Bioproducts Processing, vol. 89, no. 3, pp. 217–233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. V. Pointon, T. M. Walker, K. M. Phillips et al., “Doxorubicin in vivo rapidly alters expression and translation of myocardial electron transport chain genes, leads to ATP loss and caspase 3 activation,” PLoS One, vol. 5, no. 9, article e12733, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Z. Siddiqui, “Boswellia serrata, a potential antiinflammatory agent: an overview,” Indian Journal of Pharmaceutical Sciences, vol. 73, no. 3, pp. 255–261, 2011. View at Google Scholar
  28. J. Psotov, S. Chlopcikova, F. Grambal, V. Simanek, and J. Ulrichova, “Influence of silymarin and its flavonolignans on doxorubicin-iron induced lipid peroxidation in rat heart microsomes and mitochondria in comparison with quercetin,” Phytotherapy Research, vol. 16, pp. S63–S67, 2002. View at Publisher · View at Google Scholar
  29. N. A. El-Shitany, S. El-Haggar, and K. El-Desoky, “Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats,” Food and Chemical Toxicology, vol. 46, no. 7, pp. 2422–2428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Rašković, N. Stilinović, J. Kolarović, V. Vasović, S. Vukmirović, and M. Mikov, “The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats,” Molecules, vol. 16, no. 12, pp. 8601–8613, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. C. M. Camaggi, R. Comparsi, E. Strocchi, F. Testoni, B. Angelelli, and F. Pannuti, “Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. A cross-over study,” Cancer Chemotherapy and Pharmacology, vol. 21, no. 3, pp. 221–228, 1988. View at Publisher · View at Google Scholar · View at Scopus
  32. P. E. Ganey, F. C. Kauffman, and R. G. Thurman, “Oxygen dependent hepatotoxicity due to doxorubicin: role of reducing equivalent supply in perfused rat liver,” Molecular Pharmacology, vol. 34, no. 5, pp. 695–701, 1988. View at Google Scholar
  33. Y.-Y. Zhang, C. Meng, X.-M. Zhang et al., “Ophiopogonin D attenuates doxorubicin-induced autophagic cell death by relieving mitochondrial damage in vitro and in vivo,” The Journal of Pharmacology and Experimental Therapeutics, vol. 352, no. 1, pp. 166–174, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. O. Tacar, P. Sriamornsak, and C. R. Dass, “Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems,” Journal of Pharmacy and Pharmacology, vol. 65, no. 2, pp. 157–170, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. T. G. Neilan, S. L. Blake, F. Ichinose et al., “Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin,” Circulation, vol. 116, no. 5, pp. 506–514, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Martinez-Ruiz and S. Lamas, “Signalling by NO-induced protein S-nitrosylation and S-glutathionylation: convergences and divergences,” Cardiovascular Research, vol. 75, no. 2, pp. 220–228, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. H. J. Forman, K. J. A. Davies, and F. Ursini, “How do nutritional antioxidants really work: nucleophilic tone and para-hormesis versus free radical scavenging in vivo,” Free Radical Biology & Medicine, vol. 66, pp. 24–35, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Z. Guyton and T. W. Kensler, “Prevention of liver cancer,” Current Oncology Reports, vol. 4, no. 6, pp. 464–470, 2002. View at Publisher · View at Google Scholar
  39. N. Li, J. Alam, M. I. Venkatesan et al., “Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicals,” The Journal of Immunology, vol. 173, no. 5, pp. 3467–3481, 2004. View at Publisher · View at Google Scholar
  40. T. W. Kensler, N. Wakabayashi, and S. Biswal, “Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway,” Annual Review of Pharmacology and Toxicology, vol. 47, no. 1, pp. 89–116, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Finkel, “Signal transduction by reactive oxygen species,” The Journal of Cell Biology, vol. 194, no. 1, pp. 7–15, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. Q. Ma, “Xenobiotic-activated receptors: from transcription to drug metabolism to disease,” Chemical Research in Toxicology, vol. 21, no. 9, pp. 1651–1671, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. W. Tang, Y. F. Jiang, M. Ponnusamy, and M. Diallo, “Role of Nrf2 in chronic liver disease,” World Journal of Gastroenterology, vol. 20, no. 36, pp. 13079–13087, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. C. R. Wolf, “Chemoprevention: increased potential to bear fruit,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 6, pp. 2941–2943, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. C. A. Piantadosi, M. S. Carraway, A. Babiker, and H. B. Suliman, “Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1,” Circulation Research, vol. 103, no. 11, pp. 1232–1240, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. F. Bernuzzi, S. Recalcati, A. Alberghini, and G. Cairo, “Reactive oxygen species-independent apoptosis in doxorubicin-treated H9c2 cardiomyocytes: role for heme oxygenase-1 down-modulation,” Chemico-Biological Interactions, vol. 177, no. 1, pp. 12–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Satoh, S. R. McKercher, and S. A. Lipton, “Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs,” Free Radical Biology & Medicine, vol. 66, pp. 45–57, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. M. K. Tawfik, “Anti-aggregatory effect of boswellic acid in high-fat fed rats: involvement of redox and inflammatory cascades,” Archives of Medical Science, vol. 6, no. 6, pp. 1354–1361, 2016. View at Publisher · View at Google Scholar · View at Scopus
  49. S. S. Ahmad, S. F. Idris, G. A. Follows, and M. V. Williams, “Primary testicular lymphoma,” Clinical Oncology, vol. 24, no. 5, pp. 358–365, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. A. J. Dirks-Naylor, S. A. Kouzi, J. D. Bero, N. T. Tran, S. Yang, and R. Mabolo, “Effects of acute doxorubicin treatment on hepatic proteome lysine acetylation status and the apoptotic environment,” World Journal of Biological Chemistry, vol. 5, no. 3, pp. 377–386, 2014. View at Publisher · View at Google Scholar
  51. R. Guo, J. Lin, W. Xu et al., “Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells,” International Journal of Molecular Medicine, vol. 3, pp. 644–650, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Kruger, R. Daneshfar, G. P. Eckert et al., “Metabolism of boswellic acids in vitro and in vivo,” Drug Metabolism and Disposition, vol. 36, no. 6, pp. 1135–1142, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. O. Hovorka, V. Subr, D. Větvička et al., “Spectral analysis of doxorubicin accumulation and the indirect quantification of its DNA intercalation,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 76, no. 3, pp. 514–524, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Shimpo, T. Nagatsu, K. Yamada et al., “Ascorbic acid and adriamycin toxicity,” The American Journal of Clinical Nutrition, vol. 54, no. 6, pp. 1298S–1301S, 1991. View at Google Scholar
  55. R. Chinery, J. A. Brockman, M. O. Peeler, Y. Shyr, R. D. Beauchamp, and R. J. Coffey, “Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPβ,” Nature Medicine, vol. 3, no. 11, pp. 1233–1241, 1997. View at Publisher · View at Google Scholar
  56. P. Mukhopadhyay, M. Rajesh, S. Bátkai et al., “Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro,” American Journal of Physiology Heart and Circulatory Physiology, vol. 296, no. 5, pp. H1466–H1483, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. T. D. Oberley and L. W. Oberley, “Antioxidant enzyme levels in cancer,” Histology and Histopathology, vol. 12, no. 2, pp. 525–535, 1997. View at Google Scholar
  58. M. C. Jaramillo and D. D. Zhang, “The emerging role of the Nrf2-Keap1 signaling pathway in cancer,” Genes & Development, vol. 27, no. 20, pp. 2179–2191, 2013. View at Publisher · View at Google Scholar · View at Scopus